Blog26 February 2025 Do CROs Need to Reinvent Themselves in 2025? A Deep Dive with Greg Licholai and Derk Arts High R&D costs aren’t due to a lack of innovation but inefficiencies in trials. Here’s how we can... Learn more
Blog11 September 2024 Understanding Phase 4 Clinical Trials: A Critical Component of Post-Marketing Insight to Drugs in the Real-World When it comes to Phase 4 clinical trials, Castor's cutting-edge Real-World Evidence (RWE) platform is your key to... Learn more
